• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生产和表征展示人乳头瘤病毒次要衣壳蛋白 L2 表位的葡萄扇叶病毒样颗粒。

Production and characterization of virus-like particles of grapevine fanleaf virus presenting L2 epitope of human papillomavirus minor capsid protein.

机构信息

Plant Pathology Department, Faculty of Agriculture, Tarbiat Modares University, Pajouhesh Blvd., Tehran to Karaj highway, Tehran, Iran.

Laboratory for the Analysis of Medicines (LAM), Department of Pharmaceutical Sciences, CIRM, University of Liège, Quartier Hôpital, B36, Tower 4, Avenue Hippocrate, 15, 4000, Liège, Belgium.

出版信息

BMC Biotechnol. 2019 Nov 21;19(1):81. doi: 10.1186/s12896-019-0566-y.

DOI:10.1186/s12896-019-0566-y
PMID:31752839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6868843/
Abstract

BACKGROUND

Virus-like particle (VLP) platform represents a promising approach for the generation of efficient and immunogenic subunit vaccines. Here, the feasibility of using grapevine fanleaf virus (GFLV) VLPs as a new carrier for the presentation of human papillomavirus (HPV) L2 epitope was studied. To achieve this goal, a model of the HPV L2 epitope secondary structure was predicted and its insertion within 5 external loops in the GFLV capsid protein (CP) was evaluated.

RESULTS

The epitope sequence was genetically inserted in the αB-αB domain C of the GFLV CP, which was then over-expressed in Pichia pastoris and Escherichia coli. The highest expression yield was obtained in E. coli. Using this system, VLP formation requires a denaturation-refolding step, whereas VLPs with lower production yield were directly formed using P. pastoris, as confirmed by electron microscopy and immunostaining electron microscopy. Since the GFLV L2 VLPs were found to interact with the HPV L2 antibody under native conditions in capillary electrophoresis and in ELISA, it can be assumed that the inserted epitope is located at the VLP surface with its proper ternary structure.

CONCLUSIONS

The results demonstrate that GFLV VLPs constitute a potential scaffold for surface display of the epitope of interest.

摘要

背景

病毒样颗粒(VLP)平台代表了一种生成高效和免疫原性亚单位疫苗的有前途的方法。在这里,研究了使用葡萄扇叶病毒(GFLV)VLPs 作为展示人乳头瘤病毒(HPV)L2 表位的新型载体的可行性。为了实现这一目标,预测了 HPV L2 表位的二级结构模型,并评估了其在 GFLV 衣壳蛋白(CP)5 个外部环中的插入。

结果

该表位序列被遗传插入 GFLV CP 的αB-αB 结构域 C 中,然后在毕赤酵母和大肠杆菌中过表达。在大肠杆菌中获得了最高的表达产量。使用该系统,VLP 的形成需要变性-复性步骤,而使用毕赤酵母则可以直接形成产量较低的 VLPs,这通过电子显微镜和免疫染色电子显微镜得到证实。由于在毛细管电泳和 ELISA 中发现 GFLV L2 VLPs 在天然条件下与 HPV L2 抗体相互作用,因此可以假设插入的表位位于 VLP 表面,具有适当的三元结构。

结论

结果表明,GFLV VLPs 构成了展示感兴趣表位的潜在支架。

相似文献

1
Production and characterization of virus-like particles of grapevine fanleaf virus presenting L2 epitope of human papillomavirus minor capsid protein.生产和表征展示人乳头瘤病毒次要衣壳蛋白 L2 表位的葡萄扇叶病毒样颗粒。
BMC Biotechnol. 2019 Nov 21;19(1):81. doi: 10.1186/s12896-019-0566-y.
2
Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.由L1/L2嵌合病毒样颗粒组成的人乳头瘤病毒疫苗在临床前模型中诱导产生广泛的交叉保护作用。
J Virol. 2016 Jun 24;90(14):6314-25. doi: 10.1128/JVI.00449-16. Print 2016 Jul 15.
3
Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.次要衣壳蛋白L2多表位诱导针对致癌性和黏膜型人乳头瘤病毒的广泛保护。
J Virol. 2018 Jan 30;92(4). doi: 10.1128/JVI.01930-17. Print 2018 Feb 15.
4
Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).靶向皮肤型人乳头瘤病毒(HPV)的基于嵌合L2的病毒样颗粒(VLP)疫苗
PLoS One. 2017 Jan 5;12(1):e0169533. doi: 10.1371/journal.pone.0169533. eCollection 2017.
5
VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.在毕赤酵母中表达的重组L1/L2人乳头瘤病毒16型蛋白生产病毒样颗粒
Protein Pept Lett. 2018;25(8):783-790. doi: 10.2174/0929866525666180809124633.
6
Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.呈现人乳头瘤病毒6型(HPV-6)和人乳头瘤病毒16型(HPV-16)次要衣壳蛋白L2共同中和表位的嵌合人乳头瘤病毒16型(HPV-16)L1颗粒。
J Virol. 2003 Aug;77(15):8386-93. doi: 10.1128/jvi.77.15.8386-8393.2003.
7
VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus.展示单一 L2 表位的 VLPs 诱导针对人乳头瘤病毒的广泛中和抗体。
PLoS One. 2012;7(11):e49751. doi: 10.1371/journal.pone.0049751. Epub 2012 Nov 19.
8
Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.人乳头瘤病毒31型L1/L2病毒样颗粒诱导的型特异性和交叉反应性抗体。
J Med Microbiol. 2007 Jul;56(Pt 7):907-913. doi: 10.1099/jmm.0.47073-0.
9
Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7.在 RNA 噬菌体 PP7 的病毒样颗粒上免疫展示多样化的肽,包括广泛交叉型中和人乳头瘤病毒 L2 表位。
Vaccine. 2010 Jun 17;28(27):4384-93. doi: 10.1016/j.vaccine.2010.04.049. Epub 2010 Apr 29.
10
Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations.豇豆褪绿斑驳病毒样颗粒作为表位展示支架的可行性。
BMC Biotechnol. 2015 Aug 27;15:80. doi: 10.1186/s12896-015-0180-6.

引用本文的文献

1
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded.针对人乳头瘤病毒(HPV)引发的宫颈癌的预防性疫苗:仍需要新型疫苗。
Infect Agent Cancer. 2025 Mar 10;20(1):16. doi: 10.1186/s13027-025-00643-5.
2
Unraveling Immunological Dynamics: HPV Infection in Women-Insights from Pregnancy.解析免疫动态:妊娠中的 HPV 感染——来自女性视角的洞察。
Viruses. 2023 Sep 27;15(10):2011. doi: 10.3390/v15102011.
3
Chimeric Human Papillomavirus-16 Virus-like Particles Presenting HIV-1 P18I10 Peptide: Expression, Purification, Bio-Physical Properties and Immunogenicity in BALB/c Mice.

本文引用的文献

1
The 3.3 Å structure of a plant geminivirus using cryo-EM.利用 cryo-EM 技术解析的一种植物双生病毒的 3.3Å 结构。
Nat Commun. 2018 Jun 18;9(1):2369. doi: 10.1038/s41467-018-04793-6.
2
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses.基于腺病毒的 HPV L2 疫苗可诱导广泛的交叉反应性体液免疫应答。
Vaccine. 2018 Jul 16;36(30):4462-4470. doi: 10.1016/j.vaccine.2018.06.024. Epub 2018 Jun 18.
3
Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.抗体竞争揭示 HPV L2 次要衣壳蛋白残基 17-36 的表面位置。
嵌合型人乳头瘤病毒 16 病毒样颗粒展示 HIV-1 P18I10 肽:在 BALB/c 小鼠中的表达、纯化、生物物理特性和免疫原性。
Int J Mol Sci. 2023 Apr 29;24(9):8060. doi: 10.3390/ijms24098060.
4
Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery.基于酵母的病毒样颗粒作为疫苗开发与递送的新兴平台
Vaccines (Basel). 2023 Feb 18;11(2):479. doi: 10.3390/vaccines11020479.
5
Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases.病毒样颗粒:用于开发针对新发传染病疫苗的革命性平台。
Front Microbiol. 2022 Jan 3;12:790121. doi: 10.3389/fmicb.2021.790121. eCollection 2021.
6
Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?对抗人类病毒性疾病:植物源疫苗会是答案吗?
Vaccines (Basel). 2021 Jul 8;9(7):761. doi: 10.3390/vaccines9070761.
7
In Vitro Assembly of Virus-Like Particles and Their Applications.病毒样颗粒的体外组装及其应用
Life (Basel). 2021 Apr 10;11(4):334. doi: 10.3390/life11040334.
8
Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.基于乙肝核心的病毒样颗粒:植物疫苗开发的一个平台。
Biotechnol Rep (Amst). 2021 Feb 28;29:e00605. doi: 10.1016/j.btre.2021.e00605. eCollection 2021 Mar.
9
Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases.基于L2的预防性疫苗研发进展:预防多种人乳头瘤病毒基因型及相关疾病
Vaccines (Basel). 2020 Oct 1;8(4):568. doi: 10.3390/vaccines8040568.
10
Plant Viruses and Bacteriophage-Based Reagents for Diagnosis and Therapy.植物病毒和噬菌体基诊断试剂与治疗试剂。
Annu Rev Virol. 2020 Sep 29;7(1):559-587. doi: 10.1146/annurev-virology-010720-052252.
Viruses. 2017 Nov 10;9(11):336. doi: 10.3390/v9110336.
4
Quantitation and biospecific identification of virus-like particles of human papillomavirus by capillary electrophoresis.应用毛细管电泳定量分析和鉴定人乳头瘤病毒样颗粒的生物特异性。
Talanta. 2017 Dec 1;175:325-330. doi: 10.1016/j.talanta.2017.07.046. Epub 2017 Jul 15.
5
Immobilization of catalytic virus-like particles in a flow reactor.催化性病毒样颗粒在流动反应器中的固定化。
Chem Commun (Camb). 2017 Jul 4;53(54):7632-7634. doi: 10.1039/c7cc03024j.
6
Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).靶向皮肤型人乳头瘤病毒(HPV)的基于嵌合L2的病毒样颗粒(VLP)疫苗
PLoS One. 2017 Jan 5;12(1):e0169533. doi: 10.1371/journal.pone.0169533. eCollection 2017.
7
Display of whole proteins on inner and outer surfaces of grapevine fanleaf virus-like particles.完整蛋白质在葡萄扇叶病毒样颗粒内外表面的展示。
Plant Biotechnol J. 2016 Dec;14(12):2288-2299. doi: 10.1111/pbi.12582. Epub 2016 Jul 29.
8
Engineering virus-like particles as vaccine platforms.工程化病毒样颗粒作为疫苗平台。
Curr Opin Virol. 2016 Jun;18:44-9. doi: 10.1016/j.coviro.2016.03.001. Epub 2016 Mar 29.
9
Refolding process of cysteine-rich proteins:Chitinase as a model.富含半胱氨酸蛋白质的重折叠过程:以几丁质酶为例
Rep Biochem Mol Biol. 2015 Oct;4(1):19-24.
10
Molecular pharming - VLPs made in plants.分子农场——植物中生产的病毒样颗粒。
Curr Opin Biotechnol. 2016 Feb;37:201-206. doi: 10.1016/j.copbio.2015.12.007. Epub 2016 Jan 14.